Preclinical Safety and Efficacy Data for ANPD001 Presented by Dr. Andres Bratt-Leal at 2023 World Parkinson Congress in Barcelona

/PRNewswire/ -- On Wednesday at the 2023 World Parkinson Congress in Barcelona, Aspen Neuroscience co-founder Andres Bratt-Leal, PhD, Senior Vice President...

Related Keywords

San Diego ,California ,United States ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Pscs Pluritest ,Danpcs Neuritest ,Andres Bratt ,World Parkinson Congress ,Research Development ,Aspen Neuroscience Inc ,Good Laboratory Practices ,Parkinson Congress ,Aspen Neuroscience ,Andres Bratt Leal ,Senior Vice President Research ,Dopamine Neuron Precursor Cells Derived ,Induced Pluripotent Stem Cells ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,